Corporate Profile  

Target Market 
 

Business Strategy
Our Story

Chairman's Message

Mission Statement

Officers & Key Personnel

   
Privacy Policy  
 

 

CardioVascular BioTherapeutics, Inc. is committed to protecting the privacy of our consumers, shareholders and users of our Website. Any user information gathered on this Website may be used for aggregate research, future improvement of the Website and to better meet your needs. CardioVascular BioTherapeutics, Inc. will not disclose personal identifiable information that you provide on this Website to any third parties other than to a CardioVascular BioTherapeutics, Inc. agent, except (1) when we have your permission or (2) to comply with valid legal requirements such as by law, regulation, warrant, subpoena or court order.

 

 

 

 



 

 

Use of this site constitutes agreement to our Terms and Conditions
and Privacy Policy. Site Design and Contents © 2008 CardioVascular BioTherapeutics, Inc. All Rights Reserved.

Some content on this site requires the free Adobe Reader.

 

7/1/2008
Dutton Associates Announces Investment Opinion: CardioVascular BioTherapeutics Maintained At Neutral Rating By Dutton Associates


6/10/2008
CVBT Inks Third Clinical Development Agreement


5/22/2008
Dr. Christopher Moore to Form ProDerm LP to Fund CVBT Wound Healing Trial


4/24/2008
CardioVascular BioTherapeutics, Inc. Funding Wound Healing Trial with R&D Partnership